Advanced Techniques in Biology & Medicine

Advanced Techniques in Biology & Medicine
Open Access

ISSN: 2379-1764

Abstract

The Role of Bradykinin and Bradykinin-Related Peptides in COVID-19: A Review

Joao Sergio Souza Moreno*, Caroline Magero Lisboa, Jessica Dotto de Lara, Micheli Mainardi Pillat

Introduction: This article discusses the global impact of COVID-19, caused by SARS-CoV-2, highlighting its symptoms, treatments, and preventive measures. It focuses on the involvement of the Kallikrein-Kinin System (KKS) and its interaction with the Renin-Angiotensin System (RAS), which contribute to the pathophysiology of severe respiratory syndrome in infected patients.

Materials and methods: This study used an integrative literature review approach, searching PubMed and Google Scholar for articles on bradykinin, COVID-19, SARS-CoV-2, and the Kallikrein-Kinin and Renin-Angiotensin systems. Studies published in the last five years were prioritized, with qualitative analysis performed.

Results: This integrative review included over 15 articles focusing on the interaction between Bradykinin (BK), SARSCoV- 2, and related systems such as the Kallikrein-Kinin System (KKS) and Renin-Angiotensin System (RAS). It highlights that SARS-CoV-2 activates these systems, triggering BK storms, increased vascular permeability, and inflammation, contributing to pulmonary edema and severe symptoms. Studies also show that viral proteins activate the KKS, intensifying BK production. B2 receptor antagonists (e.g., icatibant) and kallikrein inhibitors are promising treatments, yet more research is needed to evaluate their effectiveness and potential therapeutic benefits in COVID-19 management.

Conclusion: This study suggests that SARS-CoV-2-induced ACE2 downregulation triggers a bradykinin storm, contributing to COVID-19’s pathophysiology. B2 antagonists show potential.

Published Date: 2025-03-20; Received Date: 2025-01-17

Top